[Letter: Lasting depigmentation caused by hydroquinonemonobenzylether].
D001593:Benzyl Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D004988:Ethers, Cyclic / Q000009:adverse effects / Q000627:therapeutic use; D005145:Face; D006801:Humans; D006873:Hydroquinones / Q000009:adverse effects* / Q000627:therapeutic use; D010859:Pigmentation Disorders / Q000139:chemically induced* / Q000188:drug therapy
D001593:Benzyl Compounds; D004988:Ethers, Cyclic; D006873:Hydroquinones
Bleibende Depigmentierung durch Hydrochinonmonobenzyläther